# BridgeBio Pharma, Inc.: Form SC 13D/A, filed Oct 6, 2020

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: SC 13D/A
- Filed: 2020-10-06
- Accepted by EDGAR: Oct 6, 2020, 16:45 ET
- Period: not reported
- Accession: 0001140361-20-022590
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000114036120022590/brhc10015807_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000114036120022590/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000114036120022590/brhc10015807_sc13da.htm

Filed Oct 6, 2020.
Source: SEC EDGAR, the filing index for accession 0001140361-20-022590. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
